Latest RIGL reports update at 2024-05-07: 2024-Q12023-Q1
Rigel Pharmaceuticals logo
Rigel Pharmaceuticals RIGL
$ 1.02 2.79%

Rigel Pharmaceuticals Cash Conversion Cycle 2011-2024 | RIGL

Annual Cash Conversion Cycle Rigel Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-275 -1.02 K 165 -949 -1.06 K -6.96 K - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
165 -6.96 K -1.68 K

Quarterly Cash Conversion Cycle Rigel Pharmaceuticals

2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-24.4 203 523 -280 - 834 118 1.96 K - 2.8 K 2.75 K 57.7 79 -1.27 K -586 -1.41 K 59.9 -779 -732 -3.49 K 9.83 -7.19 K -16.5 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
2.8 K -16.5 K -1.09 K